Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This is an open labeled phase III randomized trial. The patients with clinical stage II and III will undergo mammotome biopsy of breast tumor for histologic diagnosis, immunohistochemical studies for estrogen receptor(ER), progesterone receptor(PR), HER-2/neu and others. PET results will determine the positivity of lymph node metastasis.
Critère d'inclusion
- Breast Cancer